Uher T, Blahova-Dusankova J, Horakova D, et al. Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome. J Neurol. 2014;261:1735–44.
Article
PubMed
Google Scholar
Blahova Dusankova J, Kalincik T, Dolezal T, et al. Cost of multiple sclerosis in the Czech Republic: the COMS study. Mult Scler. 2012;18:662–8.
Article
CAS
PubMed
Google Scholar
Langdon DW. Cognition in multiple sclerosis. Curr Opin Neurol. 2011;24:244–9.
Article
PubMed
Google Scholar
Cummings JL. Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology. Br J Psychiatry. 1986;149:682–97.
Article
CAS
PubMed
Google Scholar
Morgen K, Sammer G, Courtney SM, Wolters T, Melchior H, Blecker CR, Oschmann P, Kaps M, Vaitl D. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage. 2006;30:891.
Article
PubMed
Google Scholar
Ashrafi F, Behnam B, Ahmadi MA, Taheri MS, Haghighatkhah HR, Pakdaman H, Kkarrazi AM. Correlation of MRI findings and cognitive funtion in multiple sclerosis patients using montereal cognitive assessment test. Med J Islam Repub Iran. 2016;30:357.
PubMed
PubMed Central
Google Scholar
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am GeriatrSoc. 2005;53:695–9.
Article
Google Scholar
Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, et al. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging. Alzheimers Dement. 2013;9:529–37.
Article
PubMed
Google Scholar
Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RM, et al. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. MovDisord. 2008;23:297–9.
Google Scholar
Benedict RH, Zivadinov R. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol. 2011;7:332–42.
Article
PubMed
Google Scholar
Rocca MA, Amato MP, De Stefano N, et al. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol. 2015;14:302–17.
Article
PubMed
Google Scholar
Maghzi AH, Revirajan N, Julian LJ, et al. Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis. Mult Scler Relat Disord. 2014;3:720–7.
Article
PubMed
Google Scholar
Nourbakhsh B, Nunan-Saah J, Maghzi AH, et al. Longitudinal associations between MRI and cognitive changes in very early MS. Mult. Scler. Relat. Disord. 2016;5:47–52.
Article
PubMed
Google Scholar
Hyncicova E, Vyhnalek M, Kalina A, et al. Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis. J Neurol. 2017;264:482–93.
Article
PubMed
Google Scholar
Mollison D, Sellar R, Bastin M, et al. The clinic-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: a systematic review and meta-analysis. PLoS One. 2017;12:e0177727.
Article
PubMed
PubMed Central
Google Scholar
Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.
Article
PubMed
PubMed Central
Google Scholar
Noseworthy JH, et al. Interrater variability with the Expanded Disability Status Scale (EDSS) and function systems (FS) in a multiple sclerosis trial. Neurology. 1990;110:971-5.
Article
CAS
PubMed
Google Scholar
Bakshi R, Benedict RH, Bermel RA, Jacobs L. Regional brain atrophy is associated with physical disability in multiple sclerosis: Semiquantitative magnetic resonance imaging and relationship to clinical findings. J Neuroimaging. 2001;11:129–36.
Article
CAS
PubMed
Google Scholar
Kang JM, Cho Y, Park S, Lee BH, Sohn BK, Choi CH, Choi J, Jeong HY, Cho S, Lee JH, Lee J, et al. Montreal cognitive assessment reflects cognitive reserve. MBC Geriatr. 2018:18-261. https://doi.org/10.1168/s12877-0951-8.
Damian A, Jacobsen S, Hentz J, Belden C, Shill H, Sabbagh M, Caviness J, Adler C. The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord. 2011;31:126–31.
Article
PubMed
Google Scholar
Vogel SJ, Banks SJ, Cummings JL, Miller JB. Concordance of the Montreal cognitive assessment with standard neuropsychological measures. Alzheimer’s Dementia: Diagn Assess Dis Monit. 2015;1:289–94.
Google Scholar
Horakova D, Kalincik T, Blahova Dusankova J, Dolezal O. Clinical correlates of grey matter pathology in multiple sclerosis. BMC Neurol. 2012;12:10.
Article
PubMed
PubMed Central
Google Scholar
Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7:1139–51.
Article
PubMed
Google Scholar
Guimaraes J, SA MJ. Cognitive dysfunction in multiple sclerosis. Front Neurol. 2012;3:74.
Article
PubMed
PubMed Central
Google Scholar
Achiron A, Polliack M, Rao SM, et al. Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. J Neurol Neurosurg Psychiatry. 2005;76:744–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bagert B, Camplair P, Bourdette D. Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management. CNS Drugs. 2002;16:445–55.
Article
PubMed
Google Scholar
Nocentini U, Pasqualetti P, Bonavita S, Bucafusca M, De Caro MF, Farina D. Et al. Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler 2006; 12:77–87.
Article
CAS
PubMed
Google Scholar
Portaccio E, Stromillo ML, Goretti B, et al. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology. 2009;73:498–503.
Article
CAS
PubMed
Google Scholar
Khalil M, Enzinger C, Langkammer C. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Mult Sclera. 2011;17:173–80.
Article
CAS
Google Scholar
Sumowski JF, Benedict R, Enzinger C, Filippi M, et al. Cognition in multiple sclerosis: state of the field and priorities for the future. Neurology. 2018;90:278–88.
Article
PubMed
PubMed Central
Google Scholar
Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis: I: frequency, patterns, and prediction. Neurology. 1991;41:685–91.
Article
CAS
PubMed
Google Scholar
Benedict RH, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006;12:549–58.
Article
PubMed
Google Scholar
Deloire MS, Ruet A, Hamel D, Bonnet M, Dousset V, Brochet B, et al. MRI predictors of cognitive outcome in early multiple sclerosis. Neurology. 2011;76(13):1161–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lynch SG, Parmenter BA, Denney DR. The association between cognitive impairment and physical disability in multiple sclerosis. Mult Scler. 2005;11:469–76.
Article
PubMed
Google Scholar
Camp SJ, Stevenson VL, Thompson AJ, et al. Cognitive function in primary progressive and traditional progressive multiple sclerosis: controlled study with MRI correlates. Brain. 1999;122:1341–8.
Article
PubMed
Google Scholar
Benedict RH, Carone DA, Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging. 2004;14(3 Suppl):S36–45.
Article
Google Scholar
Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol. 2009;66(9):1144–50.
Article
PubMed
Google Scholar
Eijlers AJC, Van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Barkhof F, Uitdehaag BM, Schoonheim MM, Geurts J, et al. Predicting cognitive decline in multiple sclerosis: a 5- year follow-up study. Brain. 2018;141(9):2605–18.
PubMed
Google Scholar
Paul F. Pathology and MRI: exploring cognitive impairment in MS. Acta Neurol Scand. 2016;134 (Suppl. 200:24–33.
Article
PubMed
Google Scholar
Azevedo CJ, Pelletier D. Whole-brain atrophy: ready for implementation into clinical decision-making in multiple sclerosis? Curr Opin Neurol. 2016;29:237–42.
Article
CAS
PubMed
Google Scholar
Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol. 2006;5(2):158–70.
Article
PubMed
Google Scholar
De Stefano N, Stromillo ML, Giorgio A, et al. Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2016;87:93–9.
Article
PubMed
Google Scholar
Fjell AM, Walhovd KB, Fennema-Notestine C, et al. One-year brain atrophy evident in healthy aging. J Neurosci. 2009;29:15223–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vagberg M, Lindqvist T, Ambarki K, et al. Automated determination of brain parenchymal fraction in multiple sclerosis. AJNR Am J Neuroradiol. 2013;34:498–504.
Article
CAS
PubMed
Google Scholar
De Stefano N, Iannucci G, Sormani MP, et al. MR correlates of cerebral atrophy in patients with multiple sclerosis. J Neurol. 2002;249:1072–7.
Article
PubMed
Google Scholar
Dalton CM, Brex PA, Jenkins R, et al. Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002;73:141–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Foong J, Rozewicz L, Quaghebeur G, et al. Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain. 1997;120:15–26.
Article
PubMed
Google Scholar
Rossi F, Giorgio A, Battglini M, et al. Relevance of brain lesion location to cognition in relapsing multile sclerosis. PLoS One. 2012;7:e44826.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tiemann L, Penner IK, Haupts M, Schlegel U, Calabrese P. Cognitive decline in multiple sclerosis impact of topographic lesion distribution on differential cognitive deficit patterns. Mult Scler. 2009;15:1164–74.
Article
CAS
PubMed
Google Scholar
Amato MP, Ponziani G, Pracucci G, et al. Cognitive impairment in early-onset multiple sclerosis: pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol. 1995;52:168–72.
Article
CAS
PubMed
Google Scholar